Profile
Full Name
Akari Therapeutics, PlcTicker Symbol
AKTXExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
January 6, 2014Indexes
Not includedWebsite
http://www.akaritx.comEmployees
8Key Details
Price
$1.45(-0.68%)
Market cap
$41.87M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
$0.00(0.00% YoY)
PE ratio
-
Next earnings date
May 16, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Akari Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Dec 5, 22 HC Wainwright & Co.
BuyNov 1, 22 Alliance Global Partners
BuyMar 13, 20 B. Riley Securities
BuyMar 13, 20 B. Riley FBR
BuyMay 5, 18 B. Riley FBR
NeutralMar 29, 18 Canaccord Genuity
BuyFeb 8, 18 B. Riley Securities
NeutralFeb 8, 18 B. Riley FBR
NeutralSep 22, 17 William Blair
OutperformMay 31, 17 Chardan Capital
NeutralInstitutional Ownership
- What is the ticker symbol for Akari Therapeutics?
- Does Akari Therapeutics pay dividends?
- What sector is Akari Therapeutics in?
- What industry is Akari Therapeutics in?
- What country is Akari Therapeutics based in?
- When did Akari Therapeutics go public?
- Is Akari Therapeutics in the S&P 500?
- Is Akari Therapeutics in the NASDAQ 100?
- Is Akari Therapeutics in the Dow Jones?
- When was Akari Therapeutics's last earnings report?
- When does Akari Therapeutics report earnings?
- Should I buy Akari Therapeutics stock now?
What is the ticker symbol for Akari Therapeutics?
The ticker symbol for Akari Therapeutics is NASDAQ:AKTX
Does Akari Therapeutics pay dividends?
No, Akari Therapeutics does not pay dividends
What sector is Akari Therapeutics in?
Akari Therapeutics is in the Healthcare sector
What industry is Akari Therapeutics in?
Akari Therapeutics is in the Biotechnology industry
What country is Akari Therapeutics based in?
Akari Therapeutics is headquartered in United States
When did Akari Therapeutics go public?
Akari Therapeutics's initial public offering (IPO) was on January 6, 2014
Is Akari Therapeutics in the S&P 500?
No, Akari Therapeutics is not included in the S&P 500 index
Is Akari Therapeutics in the NASDAQ 100?
No, Akari Therapeutics is not included in the NASDAQ 100 index
Is Akari Therapeutics in the Dow Jones?
No, Akari Therapeutics is not included in the Dow Jones index
When was Akari Therapeutics's last earnings report?
Akari Therapeutics's most recent earnings report was on Apr 16, 2025
When does Akari Therapeutics report earnings?
The next expected earnings date for Akari Therapeutics is May 16, 2025
Should I buy Akari Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions